These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1192264)

  • 41. The Ocusert system in the management of glaucoma.
    Novak S; Stewart RH
    Tex Med; 1975 Dec; 71(12):63-5. PubMed ID: 1198344
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect on pressure after instillation of a drop of depot-pilocarpine. Clinical results of its medium-term action].
    Andermann C; Mialhe D; Arne JL; Vende D; Bec P
    J Fr Ophtalmol; 1983; 6(4):367-74. PubMed ID: 6350412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The action of stabilised pilocarpine drops on the human eye (author's transl)].
    Stodtmeister R; Brenner J; Baur MP
    Klin Monbl Augenheilkd; 1977 May; 170(5):750-3. PubMed ID: 894973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacologic effects of pilocarpine administered to normal subjects by eyedrops or by ocular therapeutic systems.
    Place VA; Fisher M; Herbst S; Gordon L; Merrill R
    Am J Ophthalmol; 1975 Oct; 80(4):706-12. PubMed ID: 1101690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-response relationships for the clinical and pharmaceutical evaluation of glaucoma drugs.
    Cowle JB; Anderson RA
    Trans Ophthalmol Soc Aust; 1967; 26():110-3. PubMed ID: 5609480
    [No Abstract]   [Full Text] [Related]  

  • 46. Subconjunctival injection of pilocarpine.
    Mehta HK
    Trans Ophthalmol Soc U K (1962); 1976 Apr; 96(1):184-8. PubMed ID: 1070854
    [No Abstract]   [Full Text] [Related]  

  • 47. Rhegmatogenous retinal detachment after initiation of ocusert therapy.
    Weseley P; Liebmann J; Ritch R
    Am J Ophthalmol; 1991 Oct; 112(4):458-9. PubMed ID: 1928251
    [No Abstract]   [Full Text] [Related]  

  • 48. Ocusert [proceedings].
    Ros F; Greve E; Dake C; Miller W
    Ophthalmologica; 1977; 175(1):38-9. PubMed ID: 904899
    [No Abstract]   [Full Text] [Related]  

  • 49. [One year's experience with pilocarpin-ocusert in the therapy of glaucoma (author's transl)].
    Lienert F; Busse H
    Klin Monbl Augenheilkd; 1975 Dec; 167(6):870-1. PubMed ID: 775179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of chronic glaucoma with pilocarpine Ocuserts.
    Hillman JS; Walker A; Davies EM
    Trans Ophthalmol Soc U K (1962); 1977 Apr; 97(1):206-9. PubMed ID: 339415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ocusert.
    Med Lett Drugs Ther; 1975 Mar; 17(6):27-8. PubMed ID: 1128448
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of a longer pilocarpine in the management of chronic simple glaucoma.
    Magder H; Boyaner D
    Can J Ophthalmol; 1974 Jul; 9(3):285-8. PubMed ID: 4844580
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of an unfixed combination of latanoprost and pilocarpine on the intraocular pressure and pupil size of normal dogs.
    Sarchahi AA; Abbasi N; Gholipour MA
    Vet Ophthalmol; 2012 Mar; 15 Suppl 1():64-70. PubMed ID: 22050700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Examination of hypotensive and miotic effects of different pilocarpine solutions (experimental investigations)].
    Kondrat'eva TS; Denisova TV; Bunin AAi ; Iakovlev AA
    Vestn Oftalmol; 1976; (2):29-31. PubMed ID: 1014180
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug delivery systems for topical ophthalmic medication.
    Halberg GP; Kelly SE; Morrone M
    Ann Ophthalmol; 1975 Sep; 7(9):1199-1204, 1207-9. PubMed ID: 1163927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction of the ocusert ocular system to an ophthalmic practice.
    Stewart RH; Novak S
    Ann Ophthalmol; 1978 Mar; 10(3):325-30. PubMed ID: 655539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interactions between macromolecular adjuvants and drugs. Part 19: In vitro and in vivo testing of polyvinyl alcohol and other macromolecular adjuvants as vehicles for eyedrops (author's transl)].
    Keipert S; Voigt R; Karst R; Nowak R
    Pharmazie; 1979 Dec; 34(12):818-24. PubMed ID: 545352
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of beta-blockers association with pilocarpine on rabbit intraocular pressure and heart rate.
    Drago F; Emmi I; Marino V
    Pharmacol Res; 1997 Apr; 35(4):299-302. PubMed ID: 9264045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose-response of topical pilocarpine in the normotensive and glaucomatous Beagle.
    Whitley RD; Gelatt KN; Gum GG
    Am J Vet Res; 1980 Mar; 41(3):417-24. PubMed ID: 7369617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ocular penetration of pilocarpine: the effect on concentration on the ocular penetration of pilocarpine.
    Ramer RM; Gasset AR
    Ann Ophthalmol; 1974 Nov; 6(11):1160-2. PubMed ID: 4429321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.